Published 1 day ago • loading... • Updated 1 day ago
Boehringer Ingelheim Canada Expands Its Global Mission to "Detect SOS" to Fill Gaps in the Analysis of the RACU that Expose Millions of Canadian Patients to Undetected Cardiac and Renal Risks
BURLINGTON, ON, Sept. 29, 2026 /CNW/ -- Boehringer Ingelheim (Canada) Ltd. continues the global expansion of the mission Detect SOS to fill
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.